Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Global Cytogenetics Market by Techniques (Comparative Genomic Hybridization, Fluorescence in Situ Hybridization, Karyotyping, Immunohistochemistry) by Application (Genetic Disorders, Cancer, Personalized Medicine) – Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

Global Cytogenetics Market was valued at USD XX Billion in the year 2017. Global Cytogenetics market is further estimated to grow at a CAGR of XX% from 2018 to reach USD XX Billion by the year 2023.

North America region holds the highest market share and Asia-Pacific is considered as the fastest growing market in the forecasted period. North America is expected to register the highest demand for Cytogenetics, owing to owing to an increase in disposable income and enhanced patient awareness of genetic disorder and cancer.

Abbott Laboratories, Agilent Technologies, Inc., Applied Spectral Imaging, Inc., Empire Genomics, LLC., Illumina, Inc., Irvine Scientific., OPKO Health, Inc. (GeneDx.), PerkinElmer Inc., Sysmex Corporation (Oxford Gene Technology), and Thermo Fisher Scientific, Inc. are the fourth and fifth-ranked players by revenue.

Drivers:

Increase in the incidence of genetic disorders and cancer

Restraints:

High cost of cytogenetic instruments

Opportunities:

Increase in focus on targeted cancer treatment

Challenges:

Environmental regulations

The global cytogenetics market is segmented into product, technique, application, end user, and region. On the basis of the product, the market is bifurcated into consumables, instruments, and software & services. The consumables segment accounted for the largest market share in 2017 and is expected to remain dominant throughout the forecast period, owing to their niche use in developed and developing economies. Furthermore, new launches such as Sysmex Corporation’s subsidiary, Oxford Gene Technology launched Cytocell Aquarius, a cost-effective fluorescence in situ hybridization (FISH) kit for the reliable investigation of glial tumors.

Key Benefits for Stakeholders

Cytogenetics manufacturers and raw material suppliers

Healthcare and pharmaceutical institution

Distributors & suppliers

Industry associations

Government & Regulatory agencies and organizations

By Product

Consumables

Testing Kits, Media, and Reagents

Probes

Others (Affinity Reagents and Stains)

Instruments

Software & Services

By Techniques

Comparative Genomic Hybridization 

Fluorescence in Situ Hybridization 

Karyotyping

Immunohistochemistry

Others

By Application

Genetic Disorders

Cancer

Personalized Medicine

Others

By End User

Clinical & Research Laboratories

Pharmaceutical & Biotechnology Companies

Academic Research Institutes

Others

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

Illumina, Inc.

Abbott Laboratories

Thermo Fisher Scientific, Inc.

Agilent Technologies, Inc.

Irvine Scientific

Applied Spectrial Imaging, Inc.

Empire Genomics, LLC

PerkinElmer, Inc.

Sysmex Corporation

OPKO Health, Inc.

(A brief overview of 10 companies is also provided in the report.)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.

Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottom-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Cytogenetics Market, By Product

6.1 Consumables

            6.1.1 Testing Kits, Media, and Reagents

            6.1.2 Probes

            6.1.3 Others (Affinity Reagents and Stains)

6.2 Instruments

6.3 Software & Services

7. Cytogenetics Market, By Technique

7.1 Comparative Genomic Hybridization 

7.2 Fluorescence in Situ Hybridization 

7.3 Karyotyping

7.4 Immunohistochemistry

7.5 Others

8. Cytogenetics Market, By Application

8.1 Genetic Disorders

8.2 Cancer

8.3 Personalized Medicine

8.4 Others

9. Cytogenetics Market, By End-Use Industry

9.1 Clinical & Research Laboratories

9.2 Pharmaceutical & Biotechnology Companies

9.3 Academic Research Institutes

9.4 Others

10. Geographical Analysis

10.1. Introduction

10.2. North America

       10.2.1. U.S.

       10.2.2. Canada

       10.2.3. Mexico

10.3. Europe

       10.3.1. U.K.

       10.3.2. Germany

       10.3.3. France

       10.3.4. RoE

10.4. Asia Pacific

       10.4.1. South Korea

       10.4.2. China

       10.4.3. Japan

       10.4.4. RoAPAC

10.5. RoW

       10.5.1. Latin America

       10.5.2. Middle East and Africa

11. Company Profiles

(Business Overview, Financial Overview, Product write up, Recent Developments)

11.1 Illumina, Inc.

11.2 Abbott Laboratories

11.3 Thermo Fisher Scientific, Inc.

11.4 Agilent Technologies, Inc.

11.5 Irvine Scientific

11.6 Applied Spectrial Imaging, Inc.

11.7 Empire Genomics, LLC

11.8 PerkinElmer, Inc.

11.9 Sysmex Corporation

11.10 OPKO Health, Inc.

(A brief overview of 10 companies is also provided in the report.)

12. Competitive Analysis

12.1. Introduction

12.2. Market Positioning of Key Players

12.3 Competitive Strategies Adopted by Leading Players

        12.3.1. Investments & Expansions

        12.3.2. New Product Launches

        12.3.3. Mergers & Acquisitions

        12.3.4. Agreements, Joint Ventures, and Partnerships

13. Appendix

13.1. Questionnaire

13.2. Available Customizations 

13.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

* The list of tables and figures will be provided in the sample report.

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports